Component
Apigenin 4′-O-glucuronide
Apigenin 4′-O-glucuronide
4 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
A parsley drink containing 118 micromoles of apiin produced a plasma Apigenin 4′-O-glucuronide peak of 153 ± 61 nM at 4 hours.
Experimental context and source evidence
- evidence_access
- Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
- experimental_model
- Four healthy men; 3.2 g parsley powder in 450 mL water.
- interpretation_status
- Recorded from source with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Apigenin collection; exact intervention and molecular form govern interpretation. · Apigenin
- plain_language
- A parsley drink containing 118 micromoles of apiin produced a plasma Apigenin 4′-O-glucuronide peak of 153 ± 61 nM at 4 hours.
- primary_references
- Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007
- source_locator
- Reviewed reference api-parsley-glucuronide; Section 3.3.2, Figure 1. These concentrations are of intact conjugates, not free apigenin.
Apigenin: detailed mechanisms of action (reviewed 10 October 2026) · lines 45–51
AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · Four healthy men; 3.2 g parsley powder in 450 mL water. · Recorded from source · Recorded from source
### api-parsley-glucuronide A parsley drink containing 118 micromoles of apiin produced a plasma Apigenin 4′-O-glucuronide peak of 153 ± 61 nM at 4 hours. Section 3.3.2, Figure 1. These concentrations are of intact conjugates, not free apigenin. Model and exposure: Four healthy men; 3.2 g parsley powder in 450 mL water. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | 2022 | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007 | Access: Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
Complete structured claim and evidence
Where it participates (unsigned role)
Chamomile tea produced the same two plasma conjugates with observed peaks at 2 hours and approximately 34% urinary recovery of measured metabolites over 24 hours.
Experimental context and source evidence
- evidence_access
- Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
- experimental_model
- Four men; tea containing 13.4 micromoles apigenin 7-O-glucoside and 1.2 micromoles parent.
- interpretation_status
- Recorded from source with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Apigenin collection; exact intervention and molecular form govern interpretation. · Apigenin
- plain_language
- Chamomile tea produced the same two plasma conjugates with observed peaks at 2 hours and approximately 34% urinary recovery of measured metabolites over 24 hours.
- primary_references
- Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007
- source_locator
- Reviewed reference api-chamomile-pk; Section 3.3.4. The different glycoside and food matrix preclude equating this with a parent capsule.
Apigenin: detailed mechanisms of action (reviewed 10 October 2026) · lines 77–83
AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · Four men; tea containing 13.4 micromoles apigenin 7-O-glucoside and 1.2 micromoles parent. · Recorded from source · Recorded from source
### api-chamomile-pk Chamomile tea produced the same two plasma conjugates with observed peaks at 2 hours and approximately 34% urinary recovery of measured metabolites over 24 hours. Section 3.3.4. The different glycoside and food matrix preclude equating this with a parent capsule. Model and exposure: Four men; tea containing 13.4 micromoles apigenin 7-O-glucoside and 1.2 micromoles parent. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | 2022 | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007 | Access: Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
Complete structured claim and evidenceThe same aglycone exposure yielded 0.9 ± 0.6 micromoles of measured urinary glucuronides over 24 hours, about 0.5% of intake.
Experimental context and source evidence
- evidence_access
- Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
- experimental_model
- Three healthy men; authentic-standard HPLC-MS.
- interpretation_status
- Recorded from source with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Apigenin collection; exact intervention and molecular form govern interpretation. · Apigenin
- plain_language
- The same aglycone exposure yielded 0.9 ± 0.6 micromoles of measured urinary glucuronides over 24 hours, about 0.5% of intake.
- primary_references
- Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007
- source_locator
- Reviewed reference api-parent-urine; Recovery of selected metabolites is not an absolute bioavailability measurement.
Apigenin: detailed mechanisms of action (reviewed 10 October 2026) · lines 37–43
AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · Three healthy men; authentic-standard HPLC-MS. · Recorded from source · Recorded from source
### api-parent-urine The same aglycone exposure yielded 0.9 ± 0.6 micromoles of measured urinary glucuronides over 24 hours, about 0.5% of intake. Recovery of selected metabolites is not an absolute bioavailability measurement. Model and exposure: Three healthy men; authentic-standard HPLC-MS. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | 2022 | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007 | Access: Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
Complete structured claim and evidenceThe yogurt/parsley preparation shifted observed conjugate peaks to the last sampled point at 6 hours or later, compared with 4 hours for the drink.
Experimental context and source evidence
- evidence_access
- Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
- experimental_contrast
- {"intervention": "Parsley with yogurt", "comparator": "Parsley drink", "endpoint": "The yogurt/parsley preparation shifted observed conjugate peaks to the last sampled point at 6 hours or later, compared with 4 hours for the drink.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; recorded from source.
- experimental_model
- Four men, 118 micromoles apiin with 100 g yogurt.
- interpretation_status
- Recorded from source with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Apigenin collection; exact intervention and molecular form govern interpretation. · Apigenin
- plain_language
- The yogurt/parsley preparation shifted observed conjugate peaks to the last sampled point at 6 hours or later, compared with 4 hours for the drink.
- primary_references
- Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007
- source_locator
- Reviewed reference api-yogurt-timing; Section 3.3.3; urinary recovery was not significantly different. Gastric emptying and matrix release were proposed explanations, not measured causal mediators.
Apigenin: detailed mechanisms of action (reviewed 10 October 2026) · lines 69–75
AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · Four men, 118 micromoles apiin with 100 g yogurt. · Recorded from source · Recorded from source
### api-yogurt-timing The yogurt/parsley preparation shifted observed conjugate peaks to the last sampled point at 6 hours or later, compared with 4 hours for the drink. Section 3.3.3; urinary recovery was not significantly different. Gastric emptying and matrix release were proposed explanations, not measured causal mediators. Model and exposure: Four men, 118 micromoles apiin with 100 g yogurt. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. | 2022 | https://pubmed.ncbi.nlm.nih.gov/35452808/ | https://doi.org/10.1016/j.freeradbiomed.2022.04.007 | Access: Full original primary-paper PDF, Methods, Results and Tables 1–7 reviewed; authentic-standard HPLC-MS analysis. PDF obtained from a public mirror; DOI and article identity verified.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.